4.960
+0,00%
2026-10-19
Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -117.0% | +54.1% | 1 / 3 | -35.1% | -20.41 pp | -40.01 pp | +3.6% | 0.32 | 12.34 | 627 | −35,1% | −45,4 | −114,3% | 12.34 | 9.65 | +27,9% |
| Pts | 0 | 12 | 4 | 0 | 0 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 4.960 (close price on 2026-10-19)EPS (TTM): 401,8
Financial charts
1.Revenue & growth
VND bn627Q2/26
1.Revenue & growth
VND bn627Q2/26
2.Profit & growth
VND bn-36,7Q2/26
3.Profit mix (Penman)
VND bn487Q2/26
4.Margins & cost structure
%43.0%Q2/26
5.Returns & cash cycle
% · days4.0%Q2/26
6.Earnings quality & cash
VND bn-628Q2/26
7.Asset structure
VND bn16.223Q2/26
8.Funding & debt health
VND bn · times16.223Q2/26
9.Revenue backlog
VND bn884Q2/26
10.Valuation
times · %12,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-63Q2/26
Adjusted EPS growth, latest quarter
-117%
Average adjusted EPS growth, 3 quarters
54.1%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26